Insulinbehovet kan øges af lægemidler med hyperglykæmisk aktivitet, f. eks. orale antikonceptiva, kortikosteroider eller thyreoideahormon substitutionsterapi, danazol, beta2- stimulerende midler (såsom ritodrin, salbutamol, terbutalin).
Insulin requirements may be increased by substances with hyperglycaemic activity, such as oral contraceptives, corticosteroids, or thyroid replacement therapy, danazol, beta2 stimulants (such as ritodrine, salbutamol, terbutaline).